SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-19-233227
Filing Date
2019-08-29
Accepted
2019-08-29 10:09:07
Documents
1
Group Members
MARUHO DEUTSCHLAND GMBH

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d906032dsc13da.htm SC 13D/A 198547
  Complete submission text file 0001193125-19-233227.txt   199966
Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Subject) CIK: 0001712641 (see all company filings)

IRS No.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90509 | Film No.: 191064223
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1-5-22 NAKATSU, KITA-KU OSAKA M0 531-0071
Business Address 1-5-22 NAKATSU, KITA-KU OSAKA M0 531-0071 81-6-6371-8876
Maruho Co., Ltd. (Filed by) CIK: 0001766945 (see all company filings)

IRS No.: 320286764
Type: SC 13D/A